1163142-17-3

Basic information

• Product Name: 4-isopropoxy-3-(methylsulfonyl)benzoic acid
• Synonyms: 4-isopropoxy-3-(methylsulfonyl)benzoic acid
• CAS NO: 1163142-17-3
• Molecular Weight: 258.295
• Mol File: 1163142-17-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 4-isopropoxy-3-(methylsulfonyl)benzoic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-isopropoxy-3-(methylsulfonyl)benzoic acid(1163142-17-3)
• EPA Substance Registry System: 4-isopropoxy-3-(methylsulfonyl)benzoic acid(1163142-17-3)

Safety Data

• Hazardous Substances Data: 1163142-17-3(Hazardous Substances Data)

Upstream product

• 213598-10-8 methyl 3-bromo-4-isopropoxybenzoate 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 213598-20-0 3-Bromo-4-iso-propoxybenzoic Acid 
• 20277-69-4 sodium methansulfinate 

Relevant articles and documents

S1P1 AGONIST AND APPLICATION THEREOF

The present invention relates to a class of tricyclic compounds and an application thereof as a sphingosine 1-phosphate type 1 (S1P1) receptor agonist. The invention specifically relates to a compound represented by formula (II), and a tautomer and pharmaceutically acceptable salt of same.

TETRAHYDROCYCLOPENTA[B]INDOL-3-YL CARBOXYLIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS

The present invention relates to certain (1,2,4-oxadiazol-3-yl)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl carboxylic acid derivatives of Formula (Ia) and pharmaceutically acceptable salts thereof, which exhibit useful pharmacological properties, for example, as agonists of the S1P1 receptor. Also provided by the present invention are pharmaceutical compositions containing compounds of the invention, and methods of using the compounds and compositions of the invention in the treatment of S1P1 associated disorders, for example, psoriasis, rheumatoid arthritis, Crohn's disease, transplant rejection, multiple sclerosis, systemic lupus erythematosus, ulcerative colitis, type I diabetes, acne, microbial infections or diseases and viral infections or diseases.